DNA Ginkgo Bioworks Holdings, Inc.
$11.27▲ +12.48%
Healthcare
Other
Pre-market
$11.27▲ +0.00%
Oct 28, 4:38 AM ET
Volume 3.01M
Avg Volume (10D) 2.18M
Key Metrics & Fundamentals
Market Cap
$758.92M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.37 - 18.22
% vs 50 MA
22.17%
% vs 200 MA
31.91%
RSI-14
55.3
MACD Histogram
-0.2500
Beta (1Y vs SPY)
3.07
Free Cash Flow
-$46.89M
Gross Rev
$20.16M
Gross Profit
$18.44M
EBITDA
-$48.22M
COGS
$1.72M
Operating Exp
$76.99M
Operating Income
-$58.55M
EBIT
-$58.55M
Pretax Income
-$57.19M
Net Income
-$46.71M
EPS (Diluted)
-0.75
Price & Volume History
Loading chart…
Recent News
What Ginkgo Bioworks Bears Saw Before The Fall
Simply Wall St. · Oct 24, 2026 1:16 AM ET
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks · Oct 20, 2026 5:15 PM ET
Ginkgo Bioworks (DNA) Stock Fair Value Edges Higher After Analysts Reassess AI Demand
Simply Wall St. · Oct 14, 2026 7:20 PM ET
Here's Why Ginkgo Bioworks Holdings, Inc. (DNA) Fell More Than Broader Market
Zacks · Oct 14, 2026 5:15 PM ET
Ginkgo Bioworks to Provide Lab Access to NSF X-Labs Researchers
MT Newswires · Oct 8, 2026 4:43 PM ET
Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program
Business Wire · Oct 8, 2026 4:10 PM ET
Ginkgo Bioworks, Araceli Biosciences Add Cellular Imaging to Autonomous Lab
MT Newswires · Oct 8, 2026 6:38 AM ET
Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop
PR Newswire · Oct 8, 2026 6:00 AM ET
Ginkgo Bioworks Holdings, Inc. (DNA) Falls More Steeply Than Broader Market: What Investors Need to Know
Zacks · Oct 7, 2026 5:15 PM ET
This Small-Cap Stock Announced a Deal With Eli Lilly. Then Its Shares Doubled
Motley Fool · Oct 5, 2026 12:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See DNA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.